Evidence map›Paper›PMID 36059903›Full record

ArticleFood bioscience2022

Nutraceutical prospects of

Aparajita Ghosh, Bijoyani Ghosh, Nidhi Parihar, Myrthong Ilaweibaphyrnai, Samir R Panda, Amit Alexander, Naveen Chella, Usn Murty, Vgm Naidu, Jagadeesh Kumar G and 1 more

Open access · greenAbstract read
In one paragraph

Article in Food bioscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Improvement of Functional Compounds and Antioxidant Activity inPreventive nutrition and food science · 2025
    Article
  6. Effects of summer supplementation ofFrontiers in veterinary science · 2025
    Article
  7. Article
  8. Article
  9. Review
  10. Multitarget-basedTzu chi medical journal
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Aparajita GhoshDepartment of Pharmacology & Toxicology, National Institute of Pharmaceutical Education and Research Guwahati, Assam, 781101, India.
Bijoyani GhoshDepartment of Pharmacology & Toxicology, National Institute of Pharmaceutical Education and Research Guwahati, Assam, 781101, India.
Nidhi PariharDepartment of Pharmacology & Toxicology, National Institute of Pharmaceutical Education and Research Guwahati, Assam, 781101, India.
Myrthong IlaweibaphyrnaiDepartment of Pharmacology & Toxicology, National Institute of Pharmaceutical Education and Research Guwahati, Assam, 781101, India.
Samir R PandaDepartment of Pharmacology & Toxicology, National Institute of Pharmaceutical Education and Research Guwahati, Assam, 781101, India.
Amit AlexanderDepartment of Pharmaceutics, National Institute of Pharmaceutical Education and Research Guwahati, Assam, 781101, India.
Naveen ChellaDepartment of Pharmaceutics, National Institute of Pharmaceutical Education and Research Guwahati, Assam, 781101, India.
Usn MurtyDepartment of Pharmacology & Toxicology, National Institute of Pharmaceutical Education and Research Guwahati, Assam, 781101, India.
Vgm NaiduDepartment of Pharmacology & Toxicology, National Institute of Pharmaceutical Education and Research Guwahati, Assam, 781101, India.
Jagadeesh Kumar GDepartment of Pharmacology & Toxicology, National Institute of Pharmaceutical Education and Research Guwahati, Assam, 781101, India.
Deepak B PemmarajuDepartment of Pharmacology & Toxicology, National Institute of Pharmaceutical Education and Research Guwahati, Assam, 781101, India.
National Institute of Pharmaceutical Education and Research · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The novel enveloped β-coronavirus SARS-CoV-2 (COVID-19) has offered a surprising health challenge all over the world. It develops severe pneumonia leading to acute respiratory distress syndrome (ARDS). Like SARS-COV-2, other encapsulated viruses like HIV, HSV, and influenza have also offered a similar challenge in the past. In this regard, many antiviral drugs are being explored with varying degrees of success to combat the associated pathological conditions. Therefore, upon scientific validation & development, these antiviral phytochemicals can attain a futuristic nutraceutical prospect in managing different encapsulated viruses.

Indexed as

Antiviral agentCOVID-19Encapsulated virusEthnomedicineGreen technologiesHouttuynia cordataNutraceutical

Identifiers

PMID36059903
PMCPMC9423882
OpenAlexW4293724011

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.